 CAMBRIDGE, Mass., Aug. 09, 2021 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR or the Company, a cell and genome engineering company, today reported financial results for the three-month period ended June 30, 2021, and provided a business update. 